Webinar: OnQ™ Prostate

January 18, 2022

In this presentation, Dr. Seibert discusses an advanced modeling framework for diffusion MRI called Restriction Spectrum Imaging (RSI) and how it yields a quantitative biomarker that has several potential applications in the diagnosis and treatment of prostate cancer.

LENGTH

Approximately 15 Minutes

PRESENTED BY

Dr. Tyler Seibert, UC San Diego

WHO SHOULD WATCH?

Radiologists
Urologists
Researchers
Primary Care Physicians

Want to see more?

10/20/2026

NeuroQuant PET Explained

Discover how NeuroQuant PET helps radiologists and neurologists move beyond visual reads.

10/13/2026

NeuroQuant PET Is Now FDA Cleared

NeuroQuant PET is now FDA cleared, with centiloid estimation for amyloid PET and support for all FDA-approved dementia tracers.

10/13/2026

Know Where Your Patient Started: Centiloids in the Era of Anti-Amyloid Therapy

Neuroradiologist Dr. Suzie Bash explains why baseline centiloid values from amyloid PET are key to anti-amyloid maintenance dosing decisions.

10/01/2026

Comprehensive Insights on Metastatic Melanoma with NeuroQuant® CT | Dr. Niky Farid

By bringing key imaging findings together into a single structured report, NeuroQuant CT helps radiologists and clinicians quickly review critical information.

10/01/2026

Transforming Prostate Cancer Care with OnQ™ Prostate

OnQ Prostate adds color-coded imaging insights that help clinicians more clearly visualize regions.

10/01/2026

Why OnQ Prostate Is Different from Other Prostate Imaging Technologies

Learn how OnQ Prostate differs from other prostate imaging technologies and how its advanced diffusion modeling can provide clearer visualization.

Our solutions

Our solutions

About

Support

Resources